A 0 1 0 1 O
known 2 7 2 7 O
history 8 15 8 15 O
of 16 18 16 18 O
HIV 19 22 19 22 B-chronic_disease
seropositivity 23 37 23 37 O

Age 0 3 38 41 B-age
≥3 4 6 42 44 O
and 7 10 45 48 O
≤21 11 14 49 52 O
years 15 20 53 58 I-upper_bound

Astrocytoma 0 11 59 70 B-cancer
, 11 12 70 71 O
Low 13 16 72 75 O
Grade 17 22 76 81 O
( 23 24 82 83 O
Fibrillary 24 34 83 93 B-cancer
astrocytoma 35 46 94 105 I-cancer
, 46 47 105 106 O
WHO 48 51 107 110 O
Grade 52 57 111 116 O
2 58 59 117 118 O
) 59 60 118 119 O
- 61 62 120 121 O
10065886 63 71 122 130 O

Astrocytoma 0 11 131 142 B-cancer
, 11 12 142 143 O
Low 13 16 144 147 O
Grade 17 22 148 153 O
( 23 24 154 155 O
Low 24 27 155 158 B-cancer
- 27 28 158 159 I-cancer
grade 28 33 159 164 I-cancer
Astrocytoma 34 45 165 176 I-cancer
, 45 46 176 177 O
NOS 47 50 178 181 O
, 50 51 181 182 O
WHO 52 55 183 186 O
Grade 56 61 187 192 O
2 62 63 193 194 O
) 63 64 194 195 O
- 65 66 196 197 O
10003571 67 75 198 206 O

Because 0 7 207 214 O
no 8 10 215 217 O
dosing 11 17 218 224 O
or 18 20 225 227 O
adverse 21 28 228 235 O
event 29 34 236 241 O
data 35 39 242 246 O
are 40 43 247 250 O
currently 44 53 251 260 O
available 54 63 261 270 O
on 64 66 271 273 O
the 67 70 274 277 O
use 71 74 278 281 O
of 75 77 282 284 O
everolimus 78 88 285 295 B-treatment
in 89 91 296 298 O
patients 92 100 299 307 O
<3 101 103 308 310 O
years 104 109 311 316 I-upper_bound
of 110 112 317 319 O
age 113 116 320 323 B-age
, 116 117 323 324 O

Close 0 5 325 330 O
contact 6 13 331 338 O
with 14 18 339 343 O
those 19 24 344 349 O
who 25 28 350 353 O
have 29 33 354 358 O
received 34 42 359 367 O
attenuated 43 53 368 378 O
live 54 58 379 383 B-treatment
vaccines 59 67 384 392 I-treatment
should 68 74 393 399 O
be 75 77 400 402 O
avoided 78 85 403 410 O
during 86 92 411 417 O
treatment 93 102 418 427 B-treatment
with 103 107 428 432 O
everolimus 108 118 433 443 B-treatment

Female 0 6 444 450 B-gender
patients 7 15 451 459 I-gender
of 16 18 460 462 O
child 19 24 463 468 O
bearing 25 32 469 476 O
potential 33 42 477 486 O
must 43 47 487 491 O
not 48 51 492 495 O
be 52 54 496 498 O
breastfeeding 55 68 499 512 O
or 69 71 513 515 O
pregnant 72 80 516 524 B-pregnancy
as 81 83 525 527 O
evidenced 84 93 528 537 O
by 94 96 538 540 O
a 97 98 541 542 O
negative 99 107 543 551 B-pregnancy
pregnancy 108 117 552 561 I-pregnancy
test 118 122 562 566 O

HIV 0 3 567 570 B-chronic_disease
- 3 4 570 571 O
positive 4 12 571 579 O
patients 13 21 580 588 O
on 22 24 589 591 O
combination 25 36 592 603 B-treatment
antiretroviral 37 51 604 618 I-treatment
therapy 52 59 619 626 I-treatment

Hepatitis 0 9 627 636 B-chronic_disease
B 10 11 637 638 I-chronic_disease
/ 11 12 638 639 I-chronic_disease
C 12 13 639 640 I-chronic_disease
blood 14 19 641 646 O
test 20 24 647 651 O
must 25 29 652 656 O
be 30 32 657 659 O
done 33 37 660 664 O
at 38 40 665 667 O
screening 41 50 668 677 O
for 51 54 678 681 O
all 55 58 682 685 O
patients 59 67 686 694 O

INR 0 3 695 698 B-clinical_variable
≤1.5 4 8 699 703 O
. 8 9 703 704 O
( 10 11 705 706 O
Anticoagulation 11 26 706 721 B-treatment
is 27 29 722 724 O
allowed 30 37 725 732 O
if 38 40 733 735 O
target 41 47 736 742 O
INR 48 51 743 746 O
≤ 52 53 747 748 O
1.5 54 57 749 752 O
on 58 60 753 755 O
a 61 62 756 757 O
stable 63 69 758 764 O
dose 70 74 765 769 O
of 75 77 770 772 O
warfarin 78 86 773 781 B-treatment
or 87 89 782 784 O
on 90 92 785 787 O
a 93 94 788 789 O
stable 95 101 790 796 O
dose 102 106 797 801 O
of 107 109 802 804 O
LMW 110 113 805 808 B-treatment
heparin 114 121 809 816 I-treatment
for 122 125 817 820 O
> 126 127 821 822 O
2 127 128 822 823 B-lower_bound
weeks 129 134 824 829 I-lower_bound
at 135 137 830 832 O
time 138 142 833 837 O
of 143 145 838 840 O
randomization 146 159 841 854 O
) 159 160 854 855 O

Impairment 0 10 856 866 O
of 11 13 867 869 O
gastrointestinal 14 30 870 886 O
function 31 39 887 895 O
or 40 42 896 898 O
gastrointestinal 43 59 899 915 B-chronic_disease
disease 60 67 916 923 I-chronic_disease
that 68 72 924 928 O
may 73 76 929 932 O
significantly 77 90 933 946 O
alter 91 96 947 952 O
the 97 100 953 956 O
absorption 101 111 957 967 O
of 112 114 968 970 O
everolimus 115 125 971 981 B-treatment
( 126 127 982 983 O
e.g. 127 131 983 987 O
, 131 132 987 988 O
ulcerative 133 143 989 999 B-chronic_disease
disease 144 151 1000 1007 I-chronic_disease
, 151 152 1007 1008 O
uncontrolled 153 165 1009 1021 O
nausea 166 172 1022 1028 B-chronic_disease
, 172 173 1028 1029 O
vomiting 174 182 1030 1038 B-chronic_disease
, 182 183 1038 1039 O
diarrhea 184 192 1040 1048 B-chronic_disease
, 192 193 1048 1049 O
malabsorption 194 207 1050 1063 B-chronic_disease
syndrome 208 216 1064 1072 I-chronic_disease
or 217 219 1073 1075 O
small 220 225 1076 1081 B-treatment
bowel 226 231 1082 1087 I-treatment
resection 232 241 1088 1097 I-treatment

Lansky 0 6 1098 1104 B-clinical_variable
Performance 7 18 1105 1116 I-clinical_variable
score 19 24 1117 1122 I-clinical_variable
( 25 26 1123 1124 O
if 26 28 1124 1126 O
≤ 29 30 1127 1128 O
16 31 33 1129 1131 B-upper_bound
years 34 39 1132 1137 I-upper_bound
of 40 42 1138 1140 O
age 43 46 1141 1144 B-age
) 46 47 1144 1145 O
of 48 50 1146 1148 O
≥50 51 54 1149 1152 O
by 55 57 1153 1155 O
the 58 61 1156 1159 O
time 62 66 1160 1164 O
of 67 69 1165 1167 O
registration 70 82 1168 1180 O

Life 0 4 1181 1185 B-clinical_variable
expectancy 5 15 1186 1196 I-clinical_variable
of 16 18 1197 1199 O
greater 19 26 1200 1207 O
than 27 31 1208 1212 O
8 32 33 1213 1214 B-lower_bound
weeks 34 39 1215 1220 I-lower_bound

Patient 0 7 1221 1228 O
must 8 12 1229 1233 O
have 13 17 1234 1238 O
a 18 19 1239 1240 O
Karnofsky 20 29 1241 1250 B-clinical_variable
( 30 31 1251 1252 O
if 31 33 1252 1254 O
≥ 34 35 1255 1256 O
16 36 38 1257 1259 B-lower_bound
years 39 44 1260 1265 I-lower_bound
of 45 47 1266 1268 O
age 48 51 1269 1272 B-age
) 51 52 1272 1273 O

Patients 0 8 1274 1282 O
may 9 12 1283 1286 O
have 13 17 1287 1291 O
had 18 21 1292 1295 O
treatment 22 31 1296 1305 B-treatment
( 32 33 1306 1307 O
chemotherapy 33 45 1307 1319 B-treatment
and/or 46 52 1320 1326 O
radiotherapy 53 65 1327 1339 B-treatment
) 65 66 1339 1340 O
for 67 70 1341 1344 O
any 71 74 1345 1348 O
number 75 81 1349 1355 O
of 82 84 1356 1358 O
relapses 85 93 1359 1367 O
prior 94 99 1368 1373 O
to 100 102 1374 1376 O
this 103 107 1377 1381 O
recurrence 108 118 1382 1392 O

Patients 0 8 1393 1401 O
may 9 12 1402 1405 O
not 13 16 1406 1409 O
have 17 21 1410 1414 O
therapy 22 29 1415 1422 B-treatment
for 30 33 1423 1426 O
this 34 38 1427 1431 O
recurrence 39 49 1432 1442 O
( 50 51 1443 1444 O
including 51 60 1444 1453 O
radiation 61 70 1454 1463 B-treatment
) 70 71 1463 1464 O

Patients 0 8 1465 1473 O
must 9 13 1474 1478 O
have 14 18 1479 1483 O
adequate 19 27 1484 1492 O
bone 28 32 1493 1497 O
marrow 33 39 1498 1504 O
function 40 48 1505 1513 O
( 49 50 1514 1515 O
ANC 50 53 1515 1518 B-clinical_variable
≥ 54 55 1519 1520 O
1,000 56 61 1521 1526 B-lower_bound
/ 61 62 1526 1527 I-lower_bound
mm3 62 65 1527 1530 I-lower_bound
, 65 66 1530 1531 O
platelet 67 75 1532 1540 B-clinical_variable
count 76 81 1541 1546 I-clinical_variable
of 82 84 1547 1549 O
≥ 85 86 1550 1551 O
100,000 87 94 1552 1559 B-lower_bound
/ 94 95 1559 1560 I-lower_bound
mm3 95 98 1560 1563 I-lower_bound
, 98 99 1563 1564 O
and 100 103 1565 1568 O
hemoglobin 104 114 1569 1579 B-clinical_variable
≥ 115 116 1580 1581 O
9 117 118 1582 1583 B-lower_bound
gm 119 121 1584 1586 I-lower_bound
/ 121 122 1586 1587 I-lower_bound
dL 122 124 1587 1589 I-lower_bound
) 124 125 1589 1590 O
before 126 132 1591 1597 O
starting 133 141 1598 1606 O
therapy 142 149 1607 1614 B-treatment

Patients 0 8 1615 1623 O
must 9 13 1624 1628 O
have 14 18 1629 1633 O
adequate 19 27 1634 1642 O
liver 28 33 1643 1648 O
function 34 42 1649 1657 O
( 43 44 1658 1659 O
SGPT 44 48 1659 1663 B-clinical_variable
/ 48 49 1663 1664 I-clinical_variable
ALT 49 52 1664 1667 I-clinical_variable
≤ 53 54 1668 1669 O
2.5 55 58 1670 1673 B-upper_bound
times 59 64 1674 1679 I-upper_bound
ULN 65 68 1680 1683 I-upper_bound
and 69 72 1684 1687 O
bilirubin 73 82 1688 1697 B-clinical_variable
≤ 83 84 1698 1699 O
1.5 85 88 1700 1703 B-upper_bound
times 89 94 1704 1709 I-upper_bound
ULN 95 98 1710 1713 I-upper_bound
) 98 99 1713 1714 O
before 100 106 1715 1721 O
starting 107 115 1722 1730 O
therapy 116 123 1731 1738 B-treatment

Patients 0 8 1739 1747 O
must 9 13 1748 1752 O
have 14 18 1753 1757 O
adequate 19 27 1758 1766 O
renal 28 33 1767 1772 O
function 34 42 1773 1781 O
( 43 44 1782 1783 O
serum 44 49 1783 1788 B-clinical_variable
creatinine 50 60 1789 1799 I-clinical_variable
≤ 61 62 1800 1801 O
1.5 63 66 1802 1805 B-upper_bound
times 67 72 1806 1811 I-upper_bound
institutional 73 86 1812 1825 I-upper_bound
ULN 87 90 1826 1829 I-upper_bound
for 91 94 1830 1833 O
age 95 98 1834 1837 B-age
or 99 101 1838 1840 O
GFR 102 105 1841 1844 B-clinical_variable
≥ 106 107 1845 1846 O
70 108 110 1847 1849 B-lower_bound
ml 111 113 1850 1852 I-lower_bound
/ 113 114 1852 1853 I-lower_bound
min/1.73 114 122 1853 1861 I-lower_bound
m2 123 125 1862 1864 I-lower_bound
) 125 126 1864 1865 O
before 127 133 1866 1872 O
starting 134 142 1873 1881 O
therapy 143 150 1882 1889 B-treatment

Patients 0 8 1890 1898 O
must 9 13 1899 1903 O
have 14 18 1904 1908 O
cholesterol 19 30 1909 1920 B-clinical_variable
level 31 36 1921 1926 I-clinical_variable
< 37 38 1927 1928 O
350 38 41 1928 1931 B-upper_bound
mg 42 44 1932 1934 I-upper_bound
/ 44 45 1934 1935 I-upper_bound
dL 45 47 1935 1937 I-upper_bound
and 48 51 1938 1941 O
triglycerides 52 65 1942 1955 B-clinical_variable
< 66 67 1956 1957 O
400 68 71 1958 1961 B-upper_bound
mg 72 74 1962 1964 I-upper_bound
/ 74 75 1964 1965 I-upper_bound
dL 75 77 1965 1967 I-upper_bound
before 78 84 1968 1974 O
starting 85 93 1975 1983 O
therapy 94 101 1984 1991 B-treatment

Patients 0 8 1992 2000 O
must 9 13 2001 2005 O
have 14 18 2006 2010 O
measurable 19 29 2011 2021 O
disease 30 37 2022 2029 O
, 37 38 2029 2030 O
defined 39 46 2031 2038 O
as 47 49 2039 2041 O
at 50 52 2042 2044 O
least 53 58 2045 2050 O
one 59 62 2051 2054 B-lower_bound
lesion 63 69 2055 2061 B-clinical_variable
that 70 74 2062 2066 O
can 75 78 2067 2070 O
be 79 81 2071 2073 O
accurately 82 92 2074 2084 O
measured 93 101 2085 2093 O
in 102 104 2094 2096 O
at 105 107 2097 2099 O
least 108 113 2100 2105 O
two 114 117 2106 2109 B-lower_bound
dimensions 118 128 2110 2120 O
on 129 131 2121 2123 O
MRI 132 135 2124 2127 B-treatment

Patients 0 8 2128 2136 O
must 9 13 2137 2141 O
have 14 18 2142 2146 O
normal 19 25 2147 2153 O
pulmonary 26 35 2154 2163 O
function 36 44 2164 2172 O
testing 45 52 2173 2180 O
for 53 56 2181 2184 O
age 57 60 2185 2188 B-age
based 61 66 2189 2194 O
on 67 69 2195 2197 O
pulse 70 75 2198 2203 B-treatment
oximetry 76 84 2204 2212 I-treatment

Patients 0 8 2213 2221 O
must 9 13 2222 2226 O
have 14 18 2227 2231 O
radiographic 19 31 2232 2244 O
progressive 32 43 2245 2256 O
or 44 46 2257 2259 O
recurrent 47 56 2260 2269 O
confirmed 57 66 2270 2279 O
WHO 67 70 2280 2283 O
grade 71 76 2284 2289 B-lower_bound
I 77 78 2290 2291 I-lower_bound
or 79 81 2292 2294 O
II 82 84 2295 2297 B-upper_bound
astrocytomas 85 97 2298 2310 B-clinical_variable
, 97 98 2310 2311 O
that 99 103 2312 2316 O
was 104 107 2317 2320 O
confirmed 108 117 2321 2330 O
histologically 118 132 2331 2345 O

Patients 0 8 2346 2354 O
must 9 13 2355 2359 O
have 14 18 2360 2364 O
received 19 27 2365 2373 O
their 28 33 2374 2379 O
last 34 38 2380 2384 O
dose 39 43 2385 2389 O
of 44 46 2390 2392 O
myelosuppressive 47 63 2393 2409 B-treatment
anticancer 64 74 2410 2420 I-treatment
chemotherapy 75 87 2421 2433 I-treatment
at 88 90 2434 2436 O
least 91 96 2437 2442 O
three 97 102 2443 2448 B-lower_bound
( 103 104 2449 2450 I-lower_bound
3 104 105 2450 2451 I-lower_bound
) 105 106 2451 2452 I-lower_bound
weeks 107 112 2453 2458 I-lower_bound
prior 113 118 2459 2464 I-lower_bound
to 119 121 2465 2467 O
study 122 127 2468 2473 O
registration 128 140 2474 2486 O
or 141 143 2487 2489 O
at 144 146 2490 2492 O
least 147 152 2493 2498 O
six 153 156 2499 2502 B-lower_bound
( 157 158 2503 2504 I-lower_bound
6)weeks 158 165 2504 2511 I-lower_bound
of 166 168 2512 2514 O
nitrosourea 169 180 2515 2526 B-treatment

Patients 0 8 2527 2535 O
must 9 13 2536 2540 O
have 14 18 2541 2545 O
received 19 27 2546 2554 O
their 28 33 2555 2560 O
last 34 38 2561 2565 O
dose 39 43 2566 2570 O
of 44 46 2571 2573 O
other 47 52 2574 2579 O
investigational 53 68 2580 2595 O
or 69 71 2596 2598 O
biological 72 82 2599 2609 B-clinical_variable
agent 83 88 2610 2615 I-clinical_variable
> 89 90 2616 2617 O
7 91 92 2618 2619 B-upper_bound
days 93 97 2620 2624 I-upper_bound
prior 98 103 2625 2630 I-upper_bound
to 104 106 2631 2633 O
study 107 112 2634 2639 O
entry 113 118 2640 2645 O

Patients 0 8 2646 2654 O
must 9 13 2655 2659 O
have 14 18 2660 2664 O
received 19 27 2665 2673 O
their 28 33 2674 2679 O
last 34 38 2680 2684 O
fraction 39 47 2685 2693 O
of 48 50 2694 2696 O
craniospinal 51 63 2697 2709 B-treatment
or 64 66 2710 2712 O
focal 67 72 2713 2718 B-treatment
radiation 73 82 2719 2728 I-treatment
to 83 85 2729 2731 O
primary 86 93 2732 2739 B-cancer
tumor 94 99 2740 2745 I-cancer
or 100 102 2746 2748 O
other 103 108 2749 2754 O
sites 109 114 2755 2760 O
> 115 116 2761 2762 O
12 116 118 2762 2764 B-lower_bound
weeks 119 124 2765 2770 I-lower_bound
( 125 126 2771 2772 I-lower_bound
3 126 127 2772 2773 I-lower_bound
months 128 134 2774 2780 I-lower_bound
) 134 135 2780 2781 I-lower_bound
prior 136 141 2782 2787 I-lower_bound
to 142 144 2788 2790 O
registration 145 157 2791 2803 O

Patients 0 8 2804 2812 O
receiving 9 18 2813 2822 O
any 19 22 2823 2826 O
other 23 28 2827 2832 O
concurrent 29 39 2833 2843 O
anticancer 40 50 2844 2854 B-treatment
or 51 53 2855 2857 O
investigational 54 69 2858 2873 B-treatment
therapy 70 77 2874 2881 I-treatment

Patients 0 8 2882 2890 O
receiving 9 18 2891 2900 O
chronic 19 26 2901 2908 B-treatment
, 26 27 2908 2909 O
systemic 28 36 2910 2918 B-treatment
treatment 37 46 2919 2928 I-treatment
with 47 51 2929 2933 O
corticosteroids 52 67 2934 2949 B-treatment
or 68 70 2950 2952 O
another 71 78 2953 2960 O
immunosuppressive 79 96 2961 2978 B-treatment
agent 97 102 2979 2984 I-treatment

Patients 0 8 2985 2993 O
receiving 9 18 2994 3003 O
concomitant 19 30 3004 3015 B-treatment
medication 31 41 3016 3026 I-treatment
that 42 46 3027 3031 O
may 47 50 3032 3035 O
interfere 51 60 3036 3045 O
with 61 65 3046 3050 O
study 66 71 3051 3056 O
outcome 72 79 3057 3064 O

Patients 0 8 3065 3073 O
should 9 15 3074 3080 O
not 16 19 3081 3084 O
receive 20 27 3085 3092 O
immunization 28 40 3093 3105 B-treatment
with 41 45 3106 3110 I-treatment
attenuated 46 56 3111 3121 I-treatment
live 57 61 3122 3126 I-treatment
vaccines 62 70 3127 3135 I-treatment
within 71 77 3136 3142 O
one 78 81 3143 3146 B-upper_bound
week 82 86 3147 3151 I-upper_bound
of 87 89 3152 3154 O
study 90 95 3155 3160 O
entry 96 101 3161 3166 O
or 102 104 3167 3169 O
during 105 111 3170 3176 O
study 112 117 3177 3182 O
period 118 124 3183 3189 O

Patients 0 8 3190 3198 O
who 9 12 3199 3202 O
do 13 15 3203 3205 O
not 16 19 3206 3209 O
have 20 24 3210 3214 O
measurable 25 35 3215 3225 O
disease 36 43 3226 3233 O
on 44 46 3234 3236 O
MRI 47 50 3237 3240 B-treatment

Patients 0 8 3241 3249 O
who 9 12 3250 3253 O
have 13 17 3254 3258 O
been 18 22 3259 3263 O
previously 23 33 3264 3274 O
treated 34 41 3275 3282 O
with 42 46 3283 3287 O
an 47 49 3288 3290 O
mTOR 50 54 3291 3295 B-treatment
inhibitor 55 64 3296 3305 I-treatment

Patients 0 8 3306 3314 O
who 9 12 3315 3318 O
test 13 17 3319 3323 O
positive 18 26 3324 3332 O
for 27 30 3333 3336 O
Hepatitis 31 40 3337 3346 B-chronic_disease
C 41 42 3347 3348 I-chronic_disease
antibodies 43 53 3349 3359 O
and 54 57 3360 3363 O
the 58 61 3364 3367 O
Hepatitis 62 71 3368 3377 B-chronic_disease
B 72 73 3378 3379 I-chronic_disease
antigen 74 81 3380 3387 O

Patients 0 8 3388 3396 O
with 9 13 3397 3401 O
a 14 15 3402 3403 O
known 16 21 3404 3409 O
hypersensitivity 22 38 3410 3426 O
to 39 41 3427 3429 O
everolimus 42 52 3430 3440 B-allergy_name
or 53 55 3441 3443 O
other 56 61 3444 3449 O
rapamycins 62 72 3450 3460 B-allergy_name
( 73 74 3461 3462 O
e.g. 74 78 3462 3466 O
sirolimus 79 88 3467 3476 B-allergy_name
, 88 89 3476 3477 O
temsirolimus 90 102 3478 3490 B-allergy_name
) 102 103 3490 3491 O

Patients 0 8 3492 3500 O
with 9 13 3501 3505 O
any 14 17 3506 3509 O
clinically 18 28 3510 3520 O
significant 29 40 3521 3532 O
unrelated 41 50 3533 3542 O
systemic 51 59 3543 3551 O
illness 60 67 3552 3559 O
that 68 72 3560 3564 O
would 73 78 3565 3570 O
compromise 79 89 3571 3581 O
the 90 93 3582 3585 O
patient 94 101 3586 3593 O
's 101 103 3593 3595 O
ability 104 111 3596 3603 O
to 112 114 3604 3606 O
tolerate 115 123 3607 3615 O
protocol 124 132 3616 3624 O
therapy 133 140 3625 3632 B-treatment

Patients 0 8 3633 3641 O
with 9 13 3642 3646 O
inability 14 23 3647 3656 O
to 24 26 3657 3659 O
return 27 33 3660 3666 O
for 34 37 3667 3670 O
follow 38 44 3671 3677 O
- 44 45 3677 3678 O
up 45 47 3678 3680 O
visits 48 54 3681 3687 O
to 55 57 3688 3690 O
assess 58 64 3691 3697 O
toxicity 65 73 3698 3706 O
to 74 76 3707 3709 O
therapy 77 84 3710 3717 B-treatment

Patients 0 8 3718 3726 O
with 9 13 3727 3731 O
primary 14 21 3732 3739 O
spinal 22 28 3740 3746 O
cord 29 33 3747 3751 O
tumors 34 40 3752 3758 B-cancer

Pilocytic 0 9 3759 3768 B-cancer
Astrocytoma 10 21 3769 3780 I-cancer
- 22 23 3781 3782 O
90600112 24 32 3783 3791 O

Progressive 0 11 3792 3803 O
or 12 14 3804 3806 O
recurrent 15 24 3807 3816 O
disease 25 32 3817 3824 O
should 33 39 3825 3831 O
be 40 42 3832 3834 O
based 43 48 3835 3840 O
on 49 51 3841 3843 O
MRI 52 55 3844 3847 B-treatment
according 56 65 3848 3857 O
to 66 68 3858 3860 O
the 69 72 3861 3864 O
definition 73 83 3865 3875 O
below 84 89 3876 3881 O

Topical 0 7 3882 3889 B-treatment
or 8 10 3890 3892 O
inhaled 11 18 3893 3900 B-treatment
corticosteroids 19 34 3901 3916 I-treatment

Uncontrolled 0 12 3917 3929 O
intercurrent 13 25 3930 3942 B-chronic_disease
illness 26 33 3943 3950 I-chronic_disease
including 34 43 3951 3960 O
, 43 44 3960 3961 O
but 45 48 3962 3965 O
not 49 52 3966 3969 O
limited 53 60 3970 3977 O
to 61 63 3978 3980 O
, 63 64 3980 3981 O
ongoing 65 72 3982 3989 O
or 73 75 3990 3992 O
active 76 82 3993 3999 B-chronic_disease
infection 83 92 4000 4009 I-chronic_disease
, 92 93 4009 4010 O
symptomatic 94 105 4011 4022 O
congestive 106 116 4023 4033 B-chronic_disease
heart 117 122 4034 4039 I-chronic_disease
failure 123 130 4040 4047 I-chronic_disease
, 130 131 4047 4048 O
unstable 132 140 4049 4057 B-chronic_disease
angina 141 147 4058 4064 I-chronic_disease
pectoris 148 156 4065 4073 I-chronic_disease
, 156 157 4073 4074 O
cardiac 158 165 4075 4082 B-chronic_disease
arrhythmia 166 176 4083 4093 I-chronic_disease
, 176 177 4093 4094 O
or 178 180 4095 4097 O
psychiatric 181 192 4098 4109 B-chronic_disease
illness 193 200 4110 4117 I-chronic_disease
/ 200 201 4117 4118 O
social 201 207 4118 4124 B-chronic_disease
situations 208 218 4125 4135 I-chronic_disease
that 219 223 4136 4140 O
would 224 229 4141 4146 O
limit 230 235 4147 4152 O
compliance 236 246 4153 4163 O
with 247 251 4164 4168 O
study 252 257 4169 4174 O
requirements 258 270 4175 4187 O

the 0 3 4188 4191 O
patient 4 11 4192 4199 O
can 12 15 4200 4203 O
only 16 20 4204 4208 O
be 21 23 4209 4211 O
included 24 32 4212 4220 O
after 33 38 4221 4226 O
initiation 39 49 4227 4237 O
of 50 52 4238 4240 O
appropriate 53 64 4241 4252 O
lipid 65 70 4253 4258 B-treatment
lowering 71 79 4259 4267 I-treatment
medication 80 90 4268 4278 I-treatment
and 91 94 4279 4282 O
documentation 95 108 4283 4296 O
of 109 111 4297 4299 O
cholesterol 112 123 4300 4311 B-clinical_variable
< 124 125 4312 4313 O
350mg 126 131 4314 4319 B-upper_bound
/ 131 132 4319 4320 I-upper_bound
dL 132 134 4320 4322 I-upper_bound
and 135 138 4323 4326 O
triglycerides 139 152 4327 4340 B-clinical_variable
< 153 154 4341 4342 O
400mg 155 160 4343 4348 B-upper_bound
/ 160 161 4348 4349 I-upper_bound
dl 161 163 4349 4351 I-upper_bound
before 164 170 4352 4358 O
start 171 176 4359 4364 O
of 177 179 4365 4367 O
therapy 180 187 4368 4375 B-treatment

women 0 5 4376 4381 B-gender
of 6 8 4382 4384 O
child 9 14 4385 4390 O
- 14 15 4390 4391 O
bearing 15 22 4391 4398 O
potential 23 32 4399 4408 O
and 33 36 4409 4412 O
men 37 40 4413 4416 O
must 41 45 4417 4421 O
agree 46 51 4422 4427 B-contraception_consent
to 52 54 4428 4430 I-contraception_consent
use 55 58 4431 4434 I-contraception_consent
adequate 59 67 4435 4443 I-contraception_consent
contraception 68 81 4444 4457 I-contraception_consent
( 82 83 4458 4459 O
hormonal 83 91 4459 4467 O
or 92 94 4468 4470 O
barrier 95 102 4471 4478 O
method 103 109 4479 4485 O
of 110 112 4486 4488 O
birth 113 118 4489 4494 O
control 119 126 4495 4502 O
; 126 127 4502 4503 O
abstinence 128 138 4504 4514 O
) 138 139 4514 4515 O
prior 140 145 4516 4521 O
to 146 148 4522 4524 O
study 149 154 4525 4530 O
entry 155 160 4531 4536 O
and 161 164 4537 4540 O
for 165 168 4541 4544 O
the 169 172 4545 4548 O
duration 173 181 4549 4557 O
of 182 184 4558 4560 O
study 185 190 4561 4566 O
participation 191 204 4567 4580 O

